Literature DB >> 19760259

Transgenic overexpression of the alpha-synuclein interacting protein synphilin-1 leads to behavioral and neuropathological alterations in mice.

Silke Nuber1, Thomas Franck, Hartwig Wolburg, Ulrike Schumann, Nicolas Casadei, Kristina Fischer, Carsten Calaminus, Bernd J Pichler, Sittinan Chanarat, Peter Teismann, Jörg B Schulz, Andreas R Luft, Jürgen Tomiuk, Johannes Wilbertz, Antje Bornemann, Rejko Krüger, Olaf Riess.   

Abstract

Synphilin-1 has been identified as an interacting protein of alpha-synuclein, Parkin, and LRRK2, proteins which are mutated in familial forms of Parkinson disease (PD). Subsequently, synphilin-1 has also been shown to be an intrinsic component of Lewy bodies in sporadic PD. In order to elucidate the role of synphilin-1 in the pathogenesis of PD, we generated transgenic mice overexpressing wild-type and mutant (R621C) synphilin-1 driven by a mouse prion protein promoter. Transgenic expression of both wild-type and the R621C variant synphilin-1 resulted in increased dopamine levels of the nigrostriatal system in 3-month-old mice. Furthermore, we found pathological ubiquitin-positive inclusions in cerebellar sections and dark-cell degeneration of Purkinje cells. Both transgenic mouse lines showed significant reduction of motor skill learning and motor performance. These findings suggest a pathological role of overexpressed synphilin-1 in vivo and will help to further elucidate the mechanisms of protein aggregation and neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19760259     DOI: 10.1007/s10048-009-0212-2

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  41 in total

Review 1.  Central mechanisms of motor skill learning.

Authors:  Okihide Hikosaka; Kae Nakamura; Katsuyuki Sakai; Hiroyuki Nakahara
Journal:  Curr Opin Neurobiol       Date:  2002-04       Impact factor: 6.627

2.  Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.

Authors:  K K Chung; Y Zhang; K L Lim; Y Tanaka; H Huang; J Gao; C A Ross; V L Dawson; T M Dawson
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

3.  Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain.

Authors:  P J Kahle; M Neumann; L Ozmen; V Muller; H Jacobsen; A Schindzielorz; M Okochi; U Leimer; H van Der Putten; A Probst; E Kremmer; H A Kretzschmar; C Haass
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

4.  Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease.

Authors:  M Turmaine; A Raza; A Mahal; L Mangiarini; G P Bates; S W Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

5.  Synphilin-1 is present in Lewy bodies in Parkinson's disease.

Authors:  K Wakabayashi; S Engelender; M Yoshimoto; S Tsuji; C A Ross; H Takahashi
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

6.  Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.

Authors:  George K Tofaris; Pablo Garcia Reitböck; Trevor Humby; Sarah L Lambourne; Mark O'Connell; Bernardino Ghetti; Helen Gossage; Piers C Emson; Lawrence S Wilkinson; Michel Goedert; Maria Grazia Spillantini
Journal:  J Neurosci       Date:  2006-04-12       Impact factor: 6.167

7.  Synphilin-1 transgenic mice exhibit mild motor impairments.

Authors:  Hong-Guo Jin; Hiroshi Yamashita; Takeshi Nakamura; Hiromasa Fukuba; Tetsuya Takahashi; Masanori Hiji; Tatsuo Kohriyama; Masayasu Matsumoto
Journal:  Neurosci Lett       Date:  2008-08-31       Impact factor: 3.046

8.  Aggregate formation and toxicity by wild-type and R621C synphilin-1 in the nigrostriatal system of mice using adenoviral vectors.

Authors:  Antje Krenz; Björn H Falkenburger; Ellen Gerhardt; Anja Drinkut; Jörg B Schulz
Journal:  J Neurochem       Date:  2009-01       Impact factor: 5.372

9.  Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation.

Authors:  Suzana Gispert; Domenico Del Turco; Lisa Garrett; Amy Chen; David J Bernard; John Hamm-Clement; Horst-Werner Korf; Thomas Deller; Heiko Braak; Georg Auburger; Robert L Nussbaum
Journal:  Mol Cell Neurosci       Date:  2003-10       Impact factor: 4.314

10.  Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.

Authors:  Edward Rockenstein; Margaret Mallory; Makoto Hashimoto; David Song; Clifford W Shults; Ingrid Lang; Eliezer Masliah
Journal:  J Neurosci Res       Date:  2002-06-01       Impact factor: 4.164

View more
  10 in total

Review 1.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

2.  Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model.

Authors:  Wanli W Smith; Zhaohui Liu; Yideng Liang; Naoki Masuda; Debbie A Swing; Nancy A Jenkins; Neal G Copeland; Juan C Troncoso; Mikhail Pletnikov; Ted M Dawson; Lee J Martin; Timothy H Moran; Michael K Lee; David R Borchelt; Christopher A Ross
Journal:  Hum Mol Genet       Date:  2010-02-25       Impact factor: 6.150

3.  Identification of Parkinson's disease candidate genes using CAESAR and screening of MAPT and SNCAIP in South African Parkinson's disease patients.

Authors:  Rowena J Keyser; Ekow Oppon; Jonathan A Carr; Soraya Bardien
Journal:  J Neural Transm (Vienna)       Date:  2011-02-23       Impact factor: 3.575

4.  Synphilin-1 inhibits alpha-synuclein degradation by the proteasome.

Authors:  Beatriz Alvarez-Castelao; José G Castaño
Journal:  Cell Mol Life Sci       Date:  2010-11-20       Impact factor: 9.261

5.  Synphilin-1 enhances α-synuclein aggregation in yeast and contributes to cellular stress and cell death in a Sir2-dependent manner.

Authors:  Sabrina Büttner; Charlotte Delay; Vanessa Franssens; Tine Bammens; Doris Ruli; Sandra Zaunschirm; Rita Machado de Oliveira; Tiago Fleming Outeiro; Frank Madeo; Luc Buée; Marie-Christine Galas; Joris Winderickx
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

6.  The Protein Complex of Neurodegeneration-related Phosphoinositide Phosphatase Sac3 and ArPIKfyve Binds the Lewy Body-associated Synphilin-1, Preventing Its Aggregation.

Authors:  Ognian C Ikonomov; Diego Sbrissa; Lauren M Compton; Rita Kumar; Ellen J Tisdale; Xuequn Chen; Assia Shisheva
Journal:  J Biol Chem       Date:  2015-09-24       Impact factor: 5.157

7.  A novel obesity model: synphilin-1-induced hyperphagia and obesity in mice.

Authors:  X Li; K L K Tamashiro; Z Liu; N T Bello; X Wang; S Aja; S Bi; E E Ladenheim; C A Ross; T H Moran; W W Smith
Journal:  Int J Obes (Lond)       Date:  2011-12-13       Impact factor: 5.095

8.  Gene expression analyses of the spatio-temporal relationships of human medulloblastoma subgroups during early human neurogenesis.

Authors:  Cornelia M Hooper; Susan M Hawes; Ursula R Kees; Nicholas G Gottardo; Peter B Dallas
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

9.  Yeasts as Complementary Model Systems for the Study of the Pathological Repercussions of Enhanced Synphilin-1 Glycation and Oxidation.

Authors:  David Seynnaeve; Daniel P Mulvihill; Joris Winderickx; Vanessa Franssens
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

10.  rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.

Authors:  Marusela Oliveras-Salvá; Anke Van der Perren; Nicolas Casadei; Stijn Stroobants; Silke Nuber; Rudi D'Hooge; Chris Van den Haute; Veerle Baekelandt
Journal:  Mol Neurodegener       Date:  2013-11-25       Impact factor: 14.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.